CAMBREX CORP.

Company Overview

Cambrex Corp. is a pharmaceutical company that provides products, services and technologies to accelerate the development and commercialization of small-molecule therapeutics. The company’s services include custom development, custom manufacturing, generic APIs and controlled substances. Cambrex provides pharmaceutical custom development services that range from investigational new drug support from pre-clinical to Phase III clinical trials, as well as technology transfer for commercial supply. Its development experts can support products at every stage of the lifecycle. Focusing on quality, innovation and flexibility, the company offers pharmaceutical custom manufacturing excellence on a global basis. Its small-molecule custom API manufacturing capabilities include process and analytical validation; pilot-scale manufacturing for pre-clinical studies and all phases of clinical trials, supplying milligram to kilogram quantities; commercial manufacturing for product launch and in-market supply; quality assurance and quality control; and regulatory support and filings. The company has more than 35 years of experience in generic API manufacturing. It has expertise in chiral compounds, advanced intermediates, high-potency APIs and controlled substances. In October 2016, Cambrex acquired PharmaCore Inc., a privately owned company specializing in developing, manufacturing and scaling up small-molecule APIs for clinical phase projects.

Company's Business Segments

• Product : Active Pharmaceutical Ingredients (APIs), Peptide Development, Reactor Build and Design, Others
• Service : IND Enabling services, Analytical Testing, Microbiology, Solid State Chemistry, Stabiility Storage, Others